Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01821053|
Recruitment Status : Completed
First Posted : March 29, 2013
Last Update Posted : October 16, 2015
|Condition or disease|
|Preeclampsia Type 1 Diabetes|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||85 participants|
|Official Title:||Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus|
|Study Start Date :||June 2013|
|Primary Completion Date :||September 2015|
|Study Completion Date :||October 2015|
pregestational type 1 diabetes
It is an observational study. No intervention is made.
- preeclampsia [ Time Frame: 3 years ]The development of preeclampsia, defined by hypertension ( > 140/90 mmHg) and proteinuria ( >0,3 g/24 hour).
- preterm delivery [ Time Frame: 3 years ]post-partum registration of preterm delivery
- light for gestational age [ Time Frame: 3 years ]post-partum registration of "light for gestational age"
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01821053
|Gynelogical Obstetrical Department|
|Skejby, Aarhus N, Denmark, 8200|
|Study Director:||Boye L. Jensen, Professor||cardiovascular and renal research department, Odense University Hospital|